Repeat Ivermectin Mass Drug Administrations for Malaria Control II: Protocol for a Double-blind, Cluster-Randomized, Placebo-Controlled Trial for the Integrated Control of Malaria

Autor: Brian D Foy, Anthony Some, Tereza Magalhaes, Lyndsey Gray, Sangeeta Rao, Emmanuel Sougue, Conner L Jackson, John Kittelson, Hannah C Slater, Teun Bousema, Ollo Da, A Gafar V Coulidiaty, McKenzie Colt, Martina Wade, Kacey Richards, A Fabrice Some, Roch K Dabire, Sunil Parikh

Publikováno v: JMIR Research Protocols, Vol 12, p e41197 (2023)

BackgroundThe gains made against malaria have stagnated since 2015, threatened further by increasing resistance to insecticides and antimalarials. Improvement in malaria control necessitates a multipronged strategy, which includes the development of

Externí odkaz: https://doaj.org/article/7cad2412111e4f60918cf3254f7bca6b

Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial

Autor: Hannah C Slater, Florence Fournet, André B. Sagna, François Drabo, Roch K. Dabiré, Martina Wade, Sangeeta Rao, Sunil Parikh, Jonathan A. Seaman, Brian D. Foy, Roland W Bougma, Dieudonné Diloma Soma, Tereza Magalhaes, Noel Rouamba, Abdoulaye Diabaté, A Gafar V Coulidiaty, Haoues Alout

Publikováno v: The Lancet
The Lancet, 2019, 393 (10180), pp.1517-1526. ⟨10.1016/S0140-6736(18)32321-3⟩
The Lancet, . (2019)
The Lancet, Elsevier, 2019, 393 (10180), pp.1517-1526. ⟨10.1016/S0140-6736(18)32321-3⟩

Summary Background Ivermectin is widely used in mass drug administrations for controlling neglected parasitic diseases, and can be lethal to malaria vectors that bite treated humans. Therefore, it could be a new tool to reduce plasmodium transmission

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c440036cc8e2aecdd9ba3fa0cc2b49c1
https://hal.science/hal-02434760/file/foy_lancet_2019_1.pdf